Brian Lawson appointed executive director of the Board of Pharmacy Specialties
Lawson succeeds William Ellis, who retired after 12 years of exemplary leadership as Executive Director of BPS.
Pharmacy
Trump planned pharmaceutical tariffs could raise possibility of price hikes, shortages
It’s uncertain whether tariffs will influence more companies to make more drugs in the U.S. like Trump is hoping for, some experts said.
CHPA lauds lawmakers for urging FDA to safeguard Rx-OTC pathway
“It cannot be emphasized enough how vital expanded access to OTC medicines is to public health, and the Rx-to-OTC switch process has delivered safe, effective, and affordable options for decades.”
Camber launches Lurasidone Hydrochloride Tablets
Lurasidone Hydrochloride Tablets are an atypical antipsychotic indicated for the treatment of Schizophrenia in adults and adolescents (13 to 17 years) and other depressive episodes.
Amneal donates $1.5 million to support patients during Parkinson’s Awareness Month
Amneal’s donations will be directed toward programs that offer funding support for out-of-pocket costs—including copayments, coinsurance, and deductibles—for FDA-approved Parkinson’s medications.
Dr. Debbie Kelly named 2025 Canadian Pharmacist of the Year
Dr. Kelly’s career began during the height of the HIV epidemic in the 1990s, where her early work in medication management helped improve treatment regimens and reduce side effects.
PCSC expands GDP Program with addition of four accredited companies
The Good Distribution Practices Accreditation Program aims to support pharmaceutical supply chain stakeholders, especially vendor service providers, in demonstrating compliance with globally recognized GDP operational and training standards.
Dexcom G7 15 Day receives FDA clearance
Dexcom G7 15 Day is now cleared in the U.S. for people age 18 years and above with diabetes.
Camber launches mycophenolate mofetil capsules
Mycophenolate mofetil capsules, USP 250 mg are available in 100 and 500 count bottles.
NCPA urges SCOTUS to reject radical change to legal procedure that could limit class action cases
Cases against PBMs and Big Insurers could be bogged by procedural hurdles if SCOTUS sides with petitioner, NCPA says.
FMI reaffirms 2025 advocacy agenda
To build on the momentum from Midwinter, FMI’s Government Relations Committee convened in Washington, D.C., in early March. The in-person meeting brought together food industry leaders for an in-depth policy planning session.
L’Oréal Dermatological Beauty unites industry leaders to spread sun safety awareness
Call for brands to join the effort.
Biosimilars Council's Craig Burton testifies before Congress on biosimilars crisis
Regulatory obstacles and anticompetitive abuses threaten patient care; American healthc are system on track to lose $189 billion in patient savings.
Teva and Samsung Bioepis announce Biosimilar EPYSQLI Injection now available in the U.S.
In January 2025, Teva and Samsung Bioepis entered into a strategic partnership for the commercialization of EPYSQLI in the U.S. market.
CVS Health announces chief financial officer transition plan; appoints chief medical officer
Brian Newman has been named executive vice president and chief financial officer designate, effective April 21 and Dr. Amy Compton-Phillips will be the company’s new executive vice president and chief medical officer, effective May 19.
CVS Health offers MinuteClinic health services for women
The initiative came in response to growing demand for care that acknowledges the specific challenges women face — from menopause and maternal mental health to heart health and healthy aging.